2Goldblatt J,Szer J,Fletcher JM,et al. Enzyme replacement therapy for Gaucher disease in Australia [J]. Intern Med J, 2005,35(3):156-161.
3Ciana G, Addobbati R,Tamaro G,et al. Gaucher disease and bone:Laboratory and skeletal mineral density variations during a long period of enzyme replacement therapy [J]. J Inherit Metab Dis,2005,28(5) :723-732.
4Pastores GM,Barnett NL,Kolodny EH, An open-ladel,noncomparative study of miglustat in type Ⅰ Gaucher disease:Efficacy and tolerahility over 24 months of treatment [J]. Clin Ther,2005,27 (8): 1215-1227.
5Desnick RJ. Enzyme replacement and enhancement therapy for lysosomal disease [J]. J Inherit Metab Dis, 2004, 27 (3) : 385-410.
6Yen CC,Chiou TJ ,Lin CY,et al. Allogeneic bone marrow transplantation for Gaucher disease-a case report [J]. Zhonghua Yi Xue Za Zhi(Taipei),1997,59(6):372-376.
7Cabrera-Salazar MA,Novelli E,Barranger JA. Gene therapy for the lysosomal storage disorders[J]. Curr Opin Mol Ther, 2002,4(4):349-358,
8Stirnemann J ,Caubel I, Kettaneh A,et al. Epidemiologic ,clinical,biological and therapeutic aspects of Gaucher disease[J]. Presse Med,2003,32(11) :503-511.
